The use of surrogate vascular markers in youth at risk for premature cardiovascular disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 3, 2009, Pages 195-211

  McNeal, Catherine J ^a   Wilson, D P ^a   Christou, D ^a,b   Bush, R L ^a   Shepherd, L G ^a   Santiago, J ^a   Wu, G Y ^b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Cell adhesion molecules; Children; Flow mediated vasodilatation; High sensitivity C reactive protein; Intima media thickness; Methylarginine; Risk factors; Surrogate markers; Surrogate vascular markers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; PLACEBO; PRAVASTATIN; SYMMETRIC DIMETHYLARGININE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; FLOW MEASUREMENT; FLOW MEDIATED VASODILATATION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE; OBESITY; PULSE WAVE; REVIEW; RISK ASSESSMENT; VASODILATATION; YOUNG MODULUS;

EID: 65349180839     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.3.195     Document Type: Review

References (105)

1. Mathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
2. Raitakari O, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, Järvisalo M, Uhari M, Jokinen E, Ronnemaa T, Akerblom H, Viikari J. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003; 290: 2277-2283.
3. Strong J, Malcom G, McMahan CA, Tracy R, Newman W 3rd, Herderick E, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention for the Pathological Determinants of Atherosclerosis in Youth Study. JAMA 1999; 281: 727-735.
4. Boissel J, Collet J, Moleur P, Haugh M. Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol 1992; 43: 235-244.
5. Davidson M. Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents. Am J Cardiol 2001; 87: 1A-7A.
6. Labarthe D. Prevention of cardiovascular risk factors in the first place. Prev Med 1999; 29: S72-S78.
7. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004; 173: 13-18.
8. Slyper S. Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab 2004; 89: 3089-3095.
9. Raitakari O, Celermajer D. Testing for endothelial dysfunction. Ann Med 2002; 32: 293-304.
10. Anderson T, Uehata A, Gerhard M, Meredith I, Knab S, Delagrange D, Lieberman E, Ganz P, Creager M, Yeung A, Selwyn A. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
11. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129: 111-118.
12. Corretti M, Anderson T, Benjamin E, Celermajer D, Charbormeau F, Creager M, Deanfield J, Drexler H, Gerhard-Berman M, Herrington D, Valiance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
13. Järvisalo M, Rönnemaa T, Volanen I, Kaitosaari T, Kallio K, Hartiala JJ, Irjala K, Viikari J, Simell O, Raitakari O. Brachial artery dilatation responses in healthy children and adolescents. Am J Physiol Heart Circ Physiol 2002; 282: H87-92.
14. Järvisalo M, Lehtimaki T, Raitakari O. Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 2004; 10: 2885-2889.
15. Juonala M, Viikari J, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari O. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Circulation 2004; 110: 2918-2923.
16. Witte D, Westerink J, de Koning E, van der Graaf Y, Grobbee D, Bots M. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? Am Coll Cardiol 2005; 45: 1987-1993.
17. Balletshofer B, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K, Häring H. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003; 171: 303-309.
18. de Jongh S, Ose L, Szamosi T, Gagne C, Lambert M, Scott R, Perron P, Dobbelaere D, Saborio M, Tuohy M, Stepanavage M, Sapre A, Gumbiner B, Mercuri M, van Trotsenburg P, Bakker H, Kastelein J. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002; 106: 231-237.
19. Aggoun Y, Bonnet D, Sidi D, Girardet J, Brucker E, Polak M, Safar M, Levy B. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 2070-2075.
20. Järvisalo M, Raitakari M, Toikka J, Putto-Laurila A, Rontu R, Laine S, Lehtimaki T, Ronnemaa T, Viikari J, Raitakari O. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109: 1750-1755.
21. Kadono T, Sugiyama H, Hoshiai M, Osada M, Tan T, Naitoh A, Watanabe M, Koizumi K, Nakazawa S. Endothelial fitinction evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol 2005; 26: 85-90.
22. Woo K, Chook P, Yu C, Sung R, Qiao M, Leung S, Lam C, Metreweli C, Celermajer D. Effects of diet and exercise on obesity-related vascular, dysfunction in children. Circulation 2004; 109: 81-86.
23. Brook R, Bard R, Glazewski L, Kehrer C, Bodary P, Eitzman D, Rajagopalan S. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 2004; 93: 1012-1016.
24. Kelly A, Wetzsteon R, Kaiser D, Steinberger J, Bank A, Dengel D. Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. Pediatrics 2004; 145: 731-736.
25. Celermajer D, Adams M, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield J. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-154.
26. Peña A, Wiltshire E, MacKenzie K, Gent R, Piotto L, Hirte C, Couper J. Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children. J Clin Endocrinol Metab 2006; 91: 4467-4471.
27. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol 2006; 48: 1865-1870.
28. Aggoun Y, Farpour-Lambert NJ, Marchand LM, Golay E, Maggio AB, Beghetti M. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 2008; 29: 792-799.
29. Glowińska-Olszewska B, Tolwifiska J, Urban M. Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. J Pediatr Endocrinot Metab 2007; 20: 1125-1136.
30. Martino F, Loffredo L, Carnevale R, Sanguigni V, Martino E, Catasca E, Zanoni C, Pignatelli P, Violi F. Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics 2008; 122: e648-655.
31. Fernhall B, Agiovlasitis S. Arterial function in youth: window into cardiovascular risk. J Appl Physiol 2008; 105: 325-333.
32. Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, Stuehlinger M, Lin KY, Cooke JP, Morrow JD, Ridker PM, Rifai N, Miller E, Witztum JL, Mietus-Snyder M. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003; 108: 1059-1063.
33. de Jongh S, Lilien M, Roodt J, Stroes E, Bakker H, Kastelein J. Early statin therapy restores endothelial, function in children with familial hypercholesterolemia. J Am Coll Cardiol 2002; 40: 2117-2121.
34. Mietus-Snyder M, Malloy M. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr 1998; 133: 3540.
35. de Jongh S, Lilien M, Bakker H, Hutten B, Kastelein J, Stroes E. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 2002; 163: 193-197.
36. Sorensen K, Celermajer D, Spiegelhalter D, Georgakopoulos D, Robinson J, Thomas O, Deanfield J. Non-invasive measurement of human endotheliurn dependent arterial responses: accuracy and reproducibility. Br Heart J 1995; 74: 247-253.
37. West SG, Wagner P, Schoemer SL, Hecker KD, Hurston KL, Likos Krick A, Boseska L, Ulbrecht J, Hinderliter AL. Biological correlates of day-to-day variation in flow-mediated dilation in individuals with type 2 diabetes: a study of test-retest reliability. Diabetologia 2004; 47: 1625-1631.
38. De Roos N, Bots M, Schouten E, Katan M. Within-subject variability of flow-mediated vasodilation of the brachial artery in healthy men and women: implications for experimental studies. Ultrasound Med Biol 2003; 29: 401-406.
39. Redberg R, Vogel R, Criqui M, Herrington D, Lima J, Roman M. 34th Bethesda Conference: Task force #3-What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J Am Coll Cardiol 2003; 41: 1886-1898.
40. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
41. Burke A, Virmani R, Galis Z, Haudenschild C, Muller J. 34th Bethesda Conference: Task force #2-What is the pathologic basis for new atherosclerosis imaging techniques? J Am Coll Cardiol 2003; 41: 1874-1886.
42. Fathi R, Marwick T. Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J 2001; 141: 694-703.
43. Kanters S, Algra A, van Leeuwen M, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997; 28: 665-671.
44. Järvisalo M, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, Lehtimaki T, Simell O, Raitakari OT. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2003; 22: 1323-1328.
45. Bots M, Evans G, Riley W, Grobbee D. Carotid intimamedia thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003; 34: 2985-2994.
46. Selzer R, Mack W, Lee P, Kwong-Fu H, Hodis H. Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 2001; 154: 185-193.
47. Jourdan C, Wuhl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Troger J, Schaefer F. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005; 23: 1707-1715.
48. Sass C, Herbeth B, Chapet O, Siest G, Visvikis S, Zannad F. Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 1998; 16: 1593-1602.
49. van der Meer I, Bots M, Hofman A, del Sol A, van der Kuip D, Witteman J. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2005; 109: 1089-1094.
50. Chambless L, Heiss G, Folsom A, Rosamond W, Szklo M, Sharrett AR, Clegg L. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
51. Li S, Chen W, Srinivasan S, Bond G, Tang R, Urbina E, Berenson G. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 2003; 290: 2271-2276.
52. Davis P, Dawson J, Riley W, Lauer R. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104: 2815-2819.
53. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren T, Ose L, Russell D, Bonaa K. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996; 16: 984-991.
54. Wiegman A, de Groot E, Autten B, Rodenburg J, Gort J, Bakker H, Sijbrands E, Kastelein J. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaernia. Lancet 2004; 363: 369-370.
55. Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 1998; 21: 1004-1007.
56. Sorof J, Alexandrov A, Cardwell G, Portman R. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111: 61-66.
57. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJ. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004; 109 (Suppl 1): III33-38.
58. Wiegman A, Hutten B, de Groot E, Rodenburg J, Bakker H, Büller H, Sijbrands E, Kastelein J. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004; 292: 331-337.
59. Rodenburg J, Vissers M, Wiegman A, van Trotsenburg P, van der Graaf A, de Groot E, Wijburg F, Kastelein J, Hutten B. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation 2007; 116: 664-668.
60. Iannuzzi A, Rubba P, Pauciullo P, Celentano E, Capano G, Sartori R, Mercuri M, Bond G. Stiffness of the aortic wall in hypercholesterolemic children. Metabolism 1999; 48: 55-59.
61. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004; 173: 12-18.
62. Riley W, Freedman D, Higgs N, Barnes R, Zinkgraf S, Berenson G. Decreased arterial elasticity associated with cardiovascular disease risk factors in the young. Bogalusa Heart Study. Arteriosclerosis 1986; 6: 378-386.
63. Leeson C, Whincup P, Cook D, Mullen M, Donald A, Seymour C, Deanfield J. Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation 2000; 101: 1533-1588.
64. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358: 1400-1404.
65. Parikh A, Sochett E, McCrindle B, Dipchand A, Daneman A, Daneman D. Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes. J Pediatr 2000; 137: 465-469.
66. Aggoun Y, Farpour-Lambert NJ, Marchand LM, Golay E, Maggio AB, Beghetti M. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J. 2008;29:792-9.
67. Senzaki H, Akagi M, Hishi T, Ishizawa A, Yanagisawa M, Masutani S, Kobayashi T, Awa S. Age-associated changes in arterial elastic properties in children. Eur J Pediatr 2002; 161: 547-551.
68. Toikka J, Niemi P, Ahotupa M, Niinikoski H, Ronnemaa T, Viikari J, Hartiala J, Raitakari O. Decreased large artery distensibility in borderline hypertension is related to increased in vivo low-density lipoprotein oxidation. Scand J Clin Lab Invest 2002; 62: 301-303.
69. Toikka J, Niemi P, Ahotupa M, Niinikoski H, Ronnemaa T, Viikari J, Hartiala J, Raitakari O. Large-artery elastic properties in young men: relationships to serum lipoproteins and oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 1999; 19: 436-444.
70. Pitsavos C, Toutouzas K, Dernellis J, Skournas J, Skoumbourdis E, Stefanadis C, Toutouzas P. Aortic stiffness in young patients with heterozygous familial hypercholesterolemia. Am Heart J 1998; 135: 604-608.
71. Salomaa V, Riley W, Kark J, Nardo C, Folsom A. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995; 91: 1432-1443.
72. Henry R, Kostense P, Spijkerman A, Dekker J, Nijpels G, Heine R, Kamp O, Westerhof N, Bouter L, Stehouwer C; Hoorn Study. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003; 107: 2089-2095.
73. Li S, Chen W, Srinivasan S, Berenson G. Childhood blood pressure as a predictor of arterial stiffness in young adults: the Bogalusa Heart Study. Hypertension 2004; 43: 541-546.
74. Smilde T, van den Berkmortel F, Wollersheim H, van Langen H, Kastelein J, Stalenhoef A. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest 2000; 30: 473-480.
75. Karter Y, Curgunlu A, Erturk N, Vehid S, Mihmanli I, Ayan F. Effects of low and high doses of atorvastatin on arterial compliance. Jpn Heart J 2003; 44: 953-961.
76. Verma S, Wang C-H, Li S-H, Dumont A, Fedak P, Badiwala M, Dhillon B, Weisel R, Li R-K, Mickle D, Stewart D. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-919.
77. Ford E; National Health and Nutrition Examination Survey. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003; 108: 1053-1058.
78. Cook D, Mendall M, Whincup P, Carey I, Ballam L, Morris J, Miller G, Strachan D. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2002; 149: 139-150.
79. Wu D-M, Chu N-F, Shen M-H, Chang J-B. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2003; 56: 94-100.
80. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
81. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto A Jr, Ballantyne C. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-1338.
82. Nawawi H, Osman N, Annuar R, Khalid B, Yusoff K. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. Atherosclerosis 2003; 169: 283-291.
83. Nawawi H, Osman N, Yusoff K, Khalid B. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia. Horm Metab Res 2003; 35: 479-485.
84. Rauch U, Osende J, Chesebro J, Fuster V, Vorchheimer D, Harris K, Harris P, Sandler D, Fallon J, Jayaraman S, Badimon J. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis 2000; 153: 181-189.
85. Kavazarakis E, Moustaki M, Gourgiotis D, Zeis P, Bossios A, Mavri A, Chronopoulou A, Karpathios T. The impact of serum lipid levels on circulating soluble adhesion molecules in childhood. Pediatr Res 2002; 52: 454-458.
86. Ohta T, Saku K, Takata K, Adachi N. Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipo-protein risk factors for coronary artery disease in children. Eur J Pediatr 1999; 158: 592-598.
87. Wojakowski W, Gminski J. Soluble ICAM-1, VCAM-1 and E-selectin in children from families with high risk of atherosclerosis. Int J Mol Med 2001; 7: 181-185.
88. Kielstein J, Impraim B, Simmel S, Bode-Boger S, Tsikas D, Frolich J, Hoeper M, Haller H, Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109: 172-177.
89. Boger R. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the 1-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 2004; 134: 2842S-2847S.
90. Flynn N, Meininger C, Haynes T, Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother 2002; 56: 427-439.
91. Scalera F, Borlak J, Bechmann B, Martens-Lobenhoffer J, Thum T, Tager M, Bode-Boger S. Endogenous L-nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler Thromb Vasc Biol 2004; 24: 1816-1822.
92. Smirnova I, Kajstura M, Sawamura T, Goligorsky M. Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation. Am J Physiol Heart Circ Physiol 2004; 287: H782-H790.
93. Sydow K, Munzel T. ADMA and oxidative stress. Atheroscler Suppl 2003; 4: 41-51.
94. Stublinger M, Oka R, Graf E, Schmolzer I, Upson B, Kapoor O, Szuba A, Malinow R, Wascher T, Pachinger O, Cooke J. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethyl-arginine. Circulation 2003; 108: 933-938.
95. Lin K, Ito A, Asagami T, Tsao P, Adimoolam S, Kimoto M, Tsuji H, Reaven G, Cooke J. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002; 106: 987-992.
96. Stuhlinger M, Abbasi F, Chu J, Lamendola C, McLaughlin T, Cooke J, Reaven G, Tsac P. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287: 1420-1426.
97. Chan N, Chan J. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 2002; 45: 1609-1616.
98. Goonasekera C, Shah V, Rees D, Dillon M. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma? Blood Press 2000; 9: 16-21.
99. Sasaki S, Kuwahara N, Kunitomo K, Harada S, Yamada T, Azuma A, Takeda K, Nakagawa M. Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipo-proteinemia. Am J Cardiol 2002; 89: 386-389.
100. Eid H, Eritsland J, Larsen J, Arnesen H, Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis 2003; 166: 279-284.
101. Holven K, Haugstad T, Holm T, Aukrust P, Ose L, Nenseter M. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects. Br J Nutr 2003; 89: 359-363.
102. Goonasekera C, Rees D, Woolard P, Frend A, Shah V, Dillon M. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens 1997; 15: 901-909.
103. www.dld-diagnostika.de
104. Cohen J, Boerwinkle E, Mosley T Jr, Hobbs H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 354: 1264-1272.
105. Lauer R, Sanders S. Pediatric issues and diseases. Am Heart J 2001; 142: 224-228.